Hikma Pharmaceuticals Market Cap

Hikma Pharmaceuticals has a market cap or net worth of 4.09 billion as of November 21, 2024. Its market cap has increased by 5.30% in one year.

Market Cap

4.09B

Enterprise Value

4.91B

Revenue

2.39B

Ranking

n/a

PE Ratio

18.33

Stock Price

1,872.00

Market Cap Chart

Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 4.09B, an increase of 771.15%. That is a compound annual growth rate of 12.03%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	4.09B	3.44%
Dec 29, 2023	3.96B	15.72%
Dec 30, 2022	3.42B	-33.45%
Dec 31, 2021	5.14B	-11.50%
Dec 31, 2020	5.80B	20.30%
Dec 31, 2019	4.82B	16.44%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca PLC	155.40B
GSK plc	53.19B
Haleon plc	33.23B
Smith & Nephew plc	8.62B
ConvaTec Group PLC	4.97B
Oxford Nanopore Technologies plc	1.20B
Animalcare Group plc	143.69M

Market Cap Rankings